Trials / Completed
CompletedNCT06996184
Effect of Food on the Oral Bioavailability of a Prolonged-release Formulation of Vamifeport in Healthy Adults
A Phase 1, Randomized, Open-label Study to Characterize the Effect of Food on the Oral Bioavailability of a Prolonged-release Formulation of Vamifeport in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- CSL Behring · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a phase I, single-center, randomized, open-label, single-dose, 2-way, 2-period, crossover study to evaluate the effect of food on the pharmacokinetics (PK) of vamifeport prolonged-release (PR) formulation in healthy adult participants. Participants will be randomly allocated to one of two treatment sequences.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vamifeport (PR formulation) | Vamifeport will be administered orally |
Timeline
- Start date
- 2025-05-27
- Primary completion
- 2025-07-01
- Completion
- 2025-07-04
- First posted
- 2025-05-30
- Last updated
- 2025-11-21
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06996184. Inclusion in this directory is not an endorsement.